Bioactive Adrenomedullin, Organ Support Therapies, and Survival in the Critically Ill-Reference-Cited by-同舟云学术

Bioactive Adrenomedullin, Organ Support Therapies, and Survival in the Critically Ill

Published:2020-01 Issue:1 Volume:48 Page:49-55
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Lemasle Léa,Blet Alice,Geven Christopher,Cherifa Ményssa,Deniau Benjamin,Hollinger Alexa,Fournier Marie-Céline,Monnet Xavier,Rennuit Isabelle,Darmon Michael,Laterre Pierre-François,Struck Joachim,Hartmann Oliver,Bergmann Andreas,Mebazaa Alexandre,Gayat Etienne

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference23 articles.

1. Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma

2. Bench-to-bedside pharmacology of adrenomedullin

3. Adrenomedullin: its double-edged sword during sepsis slices yet again

4. Vasodilator Effect of Adrenomedullin and Calcitonin Gene-Related Peptide Receptors in Rat Mesenteric Vascular Beds

5. Pharmacological characterisation of the mechanisms underlying the relaxant effect of adrenomedullin in the rat carotid artery

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial;Frontiers in Medicine;2022-12-01

2. Can Acute Care Biomarkers Change Patient’s Management in Sepsis?;Eurasian Journal of Emergency Medicine;2022-06-01

3. Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care;PLOS ONE;2022-04-28

4. Identifying clinical subtypes in sepsis-survivors with different one-year outcomes: a secondary latent class analysis of the FROG-ICU cohort;Critical Care;2022-04-21

5. Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial;Journal of Clinical Medicine;2021-09-29